20th St. Gallen International Breast Cancer Conference 2027
17 March 2027 – 20 March 2027
Austria Center Vienna, Vienna, Austria
The 20th St.Gallen International Breast Cancer Conference (SGBCC 2027), the anniversary edition of the biennial conference organised by the St.Gallen Oncology Conferences (SONK) foundation, takes place in Vienna, Austria from 17 to 20 March 2027 under the title "Primary Therapy of Patients with Early Breast Cancer. Evidence, Controversies, Consensus". The programme covers updates on all relevant facets of early breast cancer care, state-of-the-art lectures and debates, and concludes with the St.Gallen International Consensus Session.
35 sessions · 84 speakers
Organiser (1)
St.Gallen Oncology Conferences (SONK)
Sponsors (5)
Menarini Stemline · AstraZeneca · Novartis · Daiichi Sankyo · Veracyte
Knowledge Partner (1)
Agenda
- Breast conserving surgery/Oncoplastic 17 March 2027 · Plenary Hall A
- Mastectomy & reconstruction 17 March 2027 · Plenary Hall A
- Industry Sponsored Symposium 17 March 2027 · Plenary Hall A
- Opening Session: Welcome, SGBCC Anniversary, Award Lecture 17 March 2027 · Plenary Hall A
- Session 1: Global Perspectives: Enhancing Breast Cancer Control through a person-centric perspective 17 March 2027 · Plenary Hall A
- Session 2: Locally Advanced Breast Cancer: Optimizing Multimodality Care 17 March 2027 · Plenary Hall A
- Industry Sponsored Symposium 18 March 2027 · Plenary Hall A
- Session 3: Innovations in Endocrine Therapy for eBC 18 March 2027 · Plenary Hall A
- SGBCC Academy - Meet the Experts I 18 March 2027 · Break-out room
- Session 4: Before Screening: The Challenges of Breast Cancer in Young Women 18 March 2027 · Plenary Hall A
- Voice of Africa 18 March 2027 · Break-out room
- Voice of China 18 March 2027 · Break-out room
- Industry Sponsored Symposium 18 March 2027 · Plenary Hall A
- Debate 1: All patients with invasive breast cancer need whole breast radiotherapy and endocrine therapy after SLNB omission 18 March 2027 · Plenary Hall A
- Session 5: Neither too much nor too little: optimal care for lower risk, stage 1 breast cancers 18 March 2027 · Plenary Hall A
- SGBCC Academy - Meet the Experts II 18 March 2027 · Break-out room
- Session 6: Refining Prognosis in eBC 18 March 2027 · Plenary Hall A
- Session 7: Combination of ADCs and Immunotherapy in Early Breast Cancer 18 March 2027 · Plenary Hall A
- Industry Sponsored Symposium 18 March 2027 · Plenary Hall A
- EBCTCG Morning Tea Session 19 March 2027 · Plenary Hall A
- Industry Sponsored Symposium 19 March 2027 · Plenary Hall A
- Session 8: Lobular Breast Cancer: A Distinct Disease 19 March 2027 · Plenary Hall A
- SGBCC Academy - Meet the Experts III 19 March 2027 · Break-out room
- Session 9: Innovative Local Therapies 19 March 2027 · Plenary Hall A
- Best Poster Awards Presentation 19 March 2027 · Plenary Hall A
- Voice of Latin America 19 March 2027 · Break-out room
- Voice of India 19 March 2027 · Break-out room
- Industry Sponsored Symposium 19 March 2027 · Plenary Hall A
- Debate 2: Tailoring Postneoadjuvant Therapy - are all non-PCR patients the same? 19 March 2027 · Plenary Hall A
- Session 10: Adjuvant Treatments for intermediate Risk, stage 1-2, HR+/HER2- Breast Cancer 19 March 2027 · Plenary Hall A
- SGBCC Academy - Meet the Experts IV 19 March 2027 · Break-out room
- Session 11: Survivorship and Quality of Life 19 March 2027 · Plenary Hall A
- Session 12: ADC Innovations in eBC 19 March 2027 · Plenary Hall A
- Industry Sponsored Symposium 19 March 2027 · Plenary Hall A
- St.Gallen International Consensus Session 20 March 2027 · Plenary Hall A